Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

International Conference on Modern Sustainable Systems (CMSS)

A Grover's Algorithm-Driven Quantum Intelligence Framework for Sustainable DNA Clinical Trial Optimization and Precision Medicine

David Raju Kuppala, R. Hariharan

Published Aug 1, 2026• 0 citations
Publisher

Abstract

While the field of genomic sequencing and DNA-based precision medicine has made tremendous strides, DNA clinical trials are still plagued with numerous problems, such as low recruitment for trials, disparate genomic data integration, difficult biomarker identification, long trial times, and inconsistent treatment decisions. Restrictions in this limit trial efficiency, cost of operation and limit the progress of sustainable precision medicine. To tackle these challenges, the authors in this paper suggest a framework for optimizing DNA clinical trial and pediatric precision medicine with quantum intelligence, based on Grover's Algorithm. The proposed framework combines all the genomic sequencing information, clinical records, biomarker profiles and therapeutic knowledge in a single quantum-assisted intelligence framework. Grover's Algorithm can be used to optimize patient recruitment and biomarker discovery in highdimensional genomic search spaces; adaptive machine learning models can be used to conduct early genetic risk assessment and for personalized therapeutic recommendations. Moreover, a sustainability conscious optimisation process not only reduces the complexity of computations, but also the use of resources and the time required for clinical trials, and keeps the predictive reliability high. The proposed framework is evaluated experimentally, which shows the accuracy of participant matching is 99.12%, the precision is 98.84%, the recall is 98.67%, the F1-score is 98.75%, and the time saved in trial optimization is 36.8% compared to the other optimization and artificial intelligence frameworks. These findings demonstrate the efficacy, scalability, and sustainability of the framework, offering valuable genomic decision support, optimizing clinical trial workflow, and paving the way for precision medicine in pediatrics.

DOI
10.1109/cmss69636.2026.11689200

Related papers

Clinical Trial Optimization via Quantum Computing for Drug Development

Kaan Karakas

Clinical trials represent one of the most resource-intensive and time-consuming phases of drug development, often constrained by complex patient stratification, high attrition rates, and logistical inefficiencies. Recent advances in quantum computing introduce new computational paradigms capable of addressing combinatorial optimization, probabilistic modeling, and high-dimensional data analysis challenges inherent in clinical research. This paper examines clinical trial optimization via quantum computing, exploring how quantum algorithms and hybrid quantum–classical frameworks can enhance patient recruitment, adaptive trial design, biomarker discovery, and outcome prediction. By synthesizing developments in quantum optimization, machine learning, and biomedical data analytics, the study evaluates the feasibility and potential impact of quantum-enabled methodologies in accelerating drug development pipelines. The findings suggest that quantum computing, when strategically integrated with classical infrastructures, may reduce development timelines, improve decision accuracy, and support more personalized and efficient clinical trial processes.

Next frontier.•Feb 7, 2026•0 citations

Quantum-Enhanced AI for Genomic Medicine

Shakila Basheer

By facilitating quicker and more precise analysis of intricate biological data, the union of quantum computing and Artificial Intelligence (AI) may transform genomic medicine and drug discovery altogether. The study suggests a model for artificial intelligence with quantum-enhanced acceleration based on hybrid quantum-classical models in order to speed up drug discovery and customize therapies. It utilizes deep learning models and Quantum Machine Learning (QML) techniques to analyze patient-specific data, protein structures, and genetic sequences. Large genomic and clinical data sets are processed by conventional deep learning models, while the quantum component carries out efficient data encoding and optimization processes. As compared to other traditional AI-based approaches, the proposed model performs a 30% improved drug target identification when evaluated against more than 1,000 genetic sequences and related clinical outcomes. The hybrid model was as accurate as 98.4% in its prediction and was more accurate than the conventional AI techniques including random forests (accuracy: 91.3%) and gradient boosting machines (accuracy: 93.7%). The methodology also produced an F1-score of 0.95 with accuracy and recall scores of 96.1% and 94.7%, respectively. These results demonstrate how quantum-enhanced AI can reduce the time for computation and improve the accuracy of genomic data analysis, driving significant progress toward personalized therapy and drug development.

CRC Press eBooks•Jun 2, 2026•0 citations

The Role of Quantum Computing and AI in Enhancing Clinical Trial Matching Efficiency

Chandani Arora, Ramandeep Sandhu, Chander Prabha +3 more

Matching eligible patients to appropriate clinical trials remains a major challenge in healthcare due to large, heterogeneous datasets and complex eligibility criteria. This paper proposes a novel Quantum Machine Learning (QML) algorithm integrated with Natural Language Processing (NLP) techniques to optimize clinical trial matching. Unlike traditional methods, the proposed framework introduces a hybrid quantum–classical pseudocode workflow that combines quantum feature mapping with NLP-based data extraction to improve accuracy and efficiency in patient–trial matching. To strengthen the foundation of the proposed approach, key patented technologies, such as US20200005906A1 (intelligent patient–trial data matching) and US20220068443A1 (NLP-based eligibility interpretation), have been considered, demonstrating the growing feasibility of automated matching systems. The novelty of our work lies in unifying these advances within a scalable QML–NLP framework that reduces manual workload, shortens trial recruitment times, and improves overall research efficiency. By integrating quantum computing with NLP, this study moves beyond existing reviews and provides a concrete, implementable methodology to accelerate patient recruitment and advance personalized medicine.

Recent Patents on Engineering•Apr 7, 2026•0 citations

Quantum computing and AI in healthcare: Accelerating complex biological simulations, genomic data processing, and drug discovery innovations

Hassan Ali

The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.

World Journal of Advanced Research and Reviews•Nov 30, 2023•48 citations

Quantum Intelligence for Personalized and Precision Medicine: Transforming Smart Healthcare Through Quantum-Enhanced Artificial Intelligence

Sohom Saha, Mahendra Kumar Singh, Prashant Kumar Choudhary

Quantum intelligence, which integrates quantum computing and artificial intelligence, is emerging as a transformative approach for personalized and precision medicine. This chapter explores its applications in genomic analysis, disease prediction, drug discovery, and clinical decision-making. Quantum machine learning can efficiently process complex healthcare datasets, enabling improved risk prediction, patient stratification, and personalized treatment. The chapter highlights applications in cancer care, cardiovascular disease prediction, rare disease diagnosis, and smart healthcare systems integrating electronic health records and Internet of Medical Things devices. It also discusses challenges related to data security, privacy, ethics, and regulatory readiness. Overall, quantum intelligence has strong potential to improve the accuracy, efficiency, and personalization of future healthcare.

Advances in computational intelligence and robotics book series•Oct 23, 2026•0 citations

QUANTUM COMPUTING AND AI IN HEALTHCARE: ACCELERATING COMPLEX BIOLOGICAL SIMULATION, GENOMIC DATA PROCESSING

Rimshath. N, Nivedha.G, Dr. Sheeja

The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI\\\'s predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning's role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug- receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual\\\'s genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions.

•Jan 1, 2026•0 citations
While the field of genomic sequencing and DNA-based precision medicine has made tremendous strides, DNA clinical trials are still plagued with numerous problems, such as low recruitment for trials, disparate genomic data integration, difficult biomarker identification, long trial times, and inconsistent treatment decisions. Restrictions in this limit trial efficiency, cost of operation and limit the progress of sustainable precision medicine. To tackle these challenges, the authors in this paper suggest a framework for optimizing DNA clinical trial and pediatric precision medicine with quantum intelligence, based on Grover's Algorithm. The proposed framework combines all the genomic sequencing information, clinical records, biomarker profiles and therapeutic knowledge in a single quantum-assisted intelligence framework. Grover's Algorithm can be used to optimize patient recruitment and biomarker discovery in highdimensional genomic search spaces; adaptive machine learning models can be used to conduct early genetic risk assessment and for personalized therapeutic recommendations. Moreover, a sustainability conscious optimisation process not only reduces the complexity of computations, but also the use of resources and the time required for clinical trials, and keeps the predictive reliability high. The proposed framework is evaluated experimentally, which shows the accuracy of participant matching is 99.12%, the precision is 98.84%, the recall is 98.67%, the F1-score is 98.75%, and the time saved in trial optimization is 36.8% compared to the other optimization and artificial intelligence frameworks. These findings demonstrate the efficacy, scalability, and sustainability of the framework, offering valuable genomic decision support, optimizing clinical trial workflow, and paving the way for precision medicine in pediatrics.
Clinical trials represent one of the most resource-intensive and time-consuming phases of drug development, often constrained by complex patient stratification, high attrition rates, and logistical inefficiencies. Recent advances in quantum computing introduce new computational paradigms capable of addressing combinatorial optimization, probabilistic modeling, and high-dimensional data analysis challenges inherent in clinical research. This paper examines clinical trial optimization via quantum computing, exploring how quantum algorithms and hybrid quantum–classical frameworks can enhance patient recruitment, adaptive trial design, biomarker discovery, and outcome prediction. By synthesizing developments in quantum optimization, machine learning, and biomedical data analytics, the study evaluates the feasibility and potential impact of quantum-enabled methodologies in accelerating drug development pipelines. The findings suggest that quantum computing, when strategically integrated with classical infrastructures, may reduce development timelines, improve decision accuracy, and support more personalized and efficient clinical trial processes.
By facilitating quicker and more precise analysis of intricate biological data, the union of quantum computing and Artificial Intelligence (AI) may transform genomic medicine and drug discovery altogether. The study suggests a model for artificial intelligence with quantum-enhanced acceleration based on hybrid quantum-classical models in order to speed up drug discovery and customize therapies. It utilizes deep learning models and Quantum Machine Learning (QML) techniques to analyze patient-specific data, protein structures, and genetic sequences. Large genomic and clinical data sets are processed by conventional deep learning models, while the quantum component carries out efficient data encoding and optimization processes. As compared to other traditional AI-based approaches, the proposed model performs a 30% improved drug target identification when evaluated against more than 1,000 genetic sequences and related clinical outcomes. The hybrid model was as accurate as 98.4% in its prediction and was more accurate than the conventional AI techniques including random forests (accuracy: 91.3%) and gradient boosting machines (accuracy: 93.7%). The methodology also produced an F1-score of 0.95 with accuracy and recall scores of 96.1% and 94.7%, respectively. These results demonstrate how quantum-enhanced AI can reduce the time for computation and improve the accuracy of genomic data analysis, driving significant progress toward personalized therapy and drug development.
Matching eligible patients to appropriate clinical trials remains a major challenge in healthcare due to large, heterogeneous datasets and complex eligibility criteria. This paper proposes a novel Quantum Machine Learning (QML) algorithm integrated with Natural Language Processing (NLP) techniques to optimize clinical trial matching. Unlike traditional methods, the proposed framework introduces a hybrid quantum–classical pseudocode workflow that combines quantum feature mapping with NLP-based data extraction to improve accuracy and efficiency in patient–trial matching. To strengthen the foundation of the proposed approach, key patented technologies, such as US20200005906A1 (intelligent patient–trial data matching) and US20220068443A1 (NLP-based eligibility interpretation), have been considered, demonstrating the growing feasibility of automated matching systems. The novelty of our work lies in unifying these advances within a scalable QML–NLP framework that reduces manual workload, shortens trial recruitment times, and improves overall research efficiency. By integrating quantum computing with NLP, this study moves beyond existing reviews and provides a concrete, implementable methodology to accelerate patient recruitment and advance personalized medicine.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.
Quantum intelligence, which integrates quantum computing and artificial intelligence, is emerging as a transformative approach for personalized and precision medicine. This chapter explores its applications in genomic analysis, disease prediction, drug discovery, and clinical decision-making. Quantum machine learning can efficiently process complex healthcare datasets, enabling improved risk prediction, patient stratification, and personalized treatment. The chapter highlights applications in cancer care, cardiovascular disease prediction, rare disease diagnosis, and smart healthcare systems integrating electronic health records and Internet of Medical Things devices. It also discusses challenges related to data security, privacy, ethics, and regulatory readiness. Overall, quantum intelligence has strong potential to improve the accuracy, efficiency, and personalization of future healthcare.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI\\\'s predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning's role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug- receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual\\\'s genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions.